UltraZyme - Enzymatic tools for ultrafast, sensitive and specific detection of viral infectious diseases at Point-Of-Care
- Funded by The Research Council of Norway (RCN)
- Total publications:0 publications
Grant number: 341642
Grant search
Key facts
Disease
N/A
Start & end year
20232025Known Financial Commitments (USD)
$506,208.61Funder
The Research Council of Norway (RCN)Principal Investigator
Atle Noralf LarsenResearch Location
NorwayLead Research Institution
UNIVERSITETET I TROMSØ - NORGES ARKTISKE UNIVERSITET, FAKULTET FOR NATURVITENSKAP OG TEKNOLOGIResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Viral pandemics such as COVID-19 represent a global health threat, and as we have all experienced, we need effective surveillance strategies to combat such large disease outbreaks. Identification of people carrying the virus is critical, and early detection is our best chance of preventing these outbreaks. Simple, super-fast and accurate tests that can be used at home or close to the patient are thus absolutely essential, and although antigen tests are easy to use and were indispensable during the peak of the COVID 19 pandemic, they still lacked the desired accuracy compared to hospital-based PCR tests. In the Ultrazyme project, we want to develop an enzyme tailored for use in molecular-based self-tests, but with the accuracy of PCR-based tests. Since the enzyme works well at room temperature, sophisticated equipment is not required. By succeeding in this project, UltraZyme can offer the enzymatic solution for a rapid and cost-effective test for disease identification and monitoring. A key element is that the test can be carried out without the use of trained personnel or own equipment.